Varenicline effects on craving, cue reactivity, and smoking reward

The role of nicotine content information in smokers' subjective responses to nicotine and placebo inhalers

(2011) Christine Darredeau et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans

(2010) K A Perkins et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Testing the influence of external and internal cues on smoking motivation using a community sample.

(2010) Erika B. Litvin et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Varenicline’s effects on acute smoking behavior and reward and their association with subsequent abstinence

(2010) Kenneth A. Perkins et al.   PSYCHOPHARMACOLOGY

Does smoking cue-induced craving tell us anything important about nicotine dependence?

(2009) Kenneth A. Perkins   ADDICTION

Comparison of methods for measurement of smoking behavior: Mouthpiece-based computerized devices versus direct observation

(2009) Melissa D. Blank et al.   NICOTINE & TOBACCO RESEARCH

The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats

(2009) Eoin C. O’Connor et al.   PSYCHOPHARMACOLOGY

Varenicline Improves Mood and Cognition During Smoking Abstinence

(2008) Freda Patterson et al.   BIOLOGICAL PSYCHIATRY